JP2011517675A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517675A5
JP2011517675A5 JP2011502041A JP2011502041A JP2011517675A5 JP 2011517675 A5 JP2011517675 A5 JP 2011517675A5 JP 2011502041 A JP2011502041 A JP 2011502041A JP 2011502041 A JP2011502041 A JP 2011502041A JP 2011517675 A5 JP2011517675 A5 JP 2011517675A5
Authority
JP
Japan
Prior art keywords
ada
igf
levels
suppressing
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011502041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011517675A (ja
JP5588963B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/038351 external-priority patent/WO2009120831A2/en
Publication of JP2011517675A publication Critical patent/JP2011517675A/ja
Publication of JP2011517675A5 publication Critical patent/JP2011517675A5/ja
Application granted granted Critical
Publication of JP5588963B2 publication Critical patent/JP5588963B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011502041A 2008-03-28 2009-03-26 Gh−rhの新規なn−およびc−末端が置換されたアンタゴニスト類似体 Active JP5588963B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4041808P 2008-03-28 2008-03-28
US61/040,418 2008-03-28
PCT/US2009/038351 WO2009120831A2 (en) 2008-03-28 2009-03-26 Novel n-and c-terminal substituted antagonistic analogs of gh-rh

Publications (3)

Publication Number Publication Date
JP2011517675A JP2011517675A (ja) 2011-06-16
JP2011517675A5 true JP2011517675A5 (enExample) 2011-11-17
JP5588963B2 JP5588963B2 (ja) 2014-09-10

Family

ID=40886425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011502041A Active JP5588963B2 (ja) 2008-03-28 2009-03-26 Gh−rhの新規なn−およびc−末端が置換されたアンタゴニスト類似体

Country Status (11)

Country Link
US (1) US8227405B2 (enExample)
EP (1) EP2288374B1 (enExample)
JP (1) JP5588963B2 (enExample)
CN (1) CN101983068B (enExample)
AU (1) AU2009228244A1 (enExample)
BR (1) BRPI0910873A2 (enExample)
CA (1) CA2718146C (enExample)
IL (1) IL208099A0 (enExample)
MX (1) MX2010010642A (enExample)
WO (1) WO2009120831A2 (enExample)
ZA (1) ZA201006843B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
WO2011153491A2 (en) 2010-06-03 2011-12-08 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
WO2014004934A2 (en) * 2012-06-27 2014-01-03 University Of Miami Compositions and methods of treating alzheimer's disease
WO2014100816A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
EP2934565B1 (en) 2012-12-21 2019-03-13 University of Miami Ghrh agonists for the treatment of ischemic disorders
WO2020163833A2 (en) * 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
JP7719466B2 (ja) 2019-07-18 2025-08-06 ユニバーシティー オブ マイアミ サルコイドーシスを処置する方法での使用のためのghrhアンタゴニスト

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651976B2 (en) * 1990-05-04 1994-08-11 The Administrators Of The Tulane Eductional Fund Novel synthetic GRF analogs
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
US6057422A (en) * 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists

Similar Documents

Publication Publication Date Title
JP2011517675A5 (enExample)
JP7566859B2 (ja) グルカゴン様ペプチド2(glp-2)類似体の投与の投薬方針
ES2925098T3 (es) Activador triple que activa el receptor de glucagón, GLP-1 Y GIP
CA2856646C (en) Combination treatment of cancer
US20160051525A1 (en) Combination therapy for proliferative disorders
JP2018504901A5 (enExample)
TWI633887B (zh) 用於預防及/或治療多囊性腎臟病之藥物
JP2017528503A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2013535437A5 (enExample)
JP2011526886A5 (enExample)
ES2946472T3 (es) Agente antitumoral y potenciador del efecto antitumoral
CN111542335A (zh) 炎症性肠病的治疗药
JP2015504073A5 (enExample)
JP2014505107A5 (enExample)
CN111936127A (zh) 炎症性疾病或骨病的预防或治疗剂及医药组合物
JP2017511377A5 (enExample)
WO2024088273A1 (zh) 一种萘酰胺化合物治疗kras突变相关疾病的用途
US20170224670A1 (en) Drug Combination to Treat Melanoma
JP2017534652A5 (enExample)
JP6232630B2 (ja) 骨系統疾患治療薬及びその用途
JP2014522414A5 (enExample)
KR102091037B1 (ko) 암-관련 카켁시아를 억제하기 위한 hdac 억제제
JP2016525530A5 (enExample)
CN109982700A (zh) 具有外显子14跳跃突变或外显子14跳跃表型的癌症的治疗